MEDIA CENTERCONTACT
Careers
Share
Market Research Report

THERAPEUTIC VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Vaccine TypePeptide-based · DNA-based · Viral Vector-based · Dendritic Cell-based · and Others
  • By Therapeutic AreaOncology · Infectious Diseases · AutoimmuneDiseases · and Others
  • By End UserHospitals · Clinics · Ambulatory Surgical Centers · andOthers
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In02 Feb 2026
  • Report CodeCMI209
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033

Table of Contents

  1. Research Objectives and Assumptions

    • Research Objectives

    • Assumptions

    • Abbreviations

  2. Market Preview

    • Report Description

      • Market Definition and Scope

    • Executive Summary

      • Market Snapshot, By Vaccine Type

      • Market Snapshot, By End User

      • Market Snapshot, By Therapeutic Area

      • Market Snapshot, By Region

    • Coherent Opportunity Map (COM)

  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics

      • Drivers

      • Restraints

      • Market Opportunities

    • Impact Analysis

    • Recent Product Launches

    • Epidemiology

    • Merger, Acquisition, and Collaboration

    • Regulatory Scenario

    • Key Developments

    • PEST Analysis

    • Partnership Scenario

    • Brand and Pricing Analysis

    • Distributors Landscape

    • Porters Analysis

    • Technological Advancements

    • Key Developments

    • Market Trend

    • Future Prospective

    • Top Market Players by Revenue

  4. Therapeutic Vaccines Market By Vaccine Type, 2026–2033, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2026 and 2033 (%)

      • Y-o-Y Growth Analysis, 2022–2033

      • Segment Trends

    • Peptide-based

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • DNA-based

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Viral Vector-based

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Dendritic Cell-based

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Others

      • Introduction 

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

  5. Therapeutic Vaccines Market By End User, 2026-2033, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2026 and 2033 (%)

      • Y-o-Y Growth Analysis, 2022–2033

      • Segment Trends

    • Hospitals

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Clinics

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Ambulatory Surgical Centers

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

  6. Therapeutic Vaccines Market By Therapeutic Area, 2026-2033, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2026 and 2033 (%)

      • Y-o-Y Growth Analysis, 2022–2033

      • Segment Trends

    • Oncology

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Infectious Diseases

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Autoimmune Diseases

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

  7. Therapeutic Vaccines Market By Region, 2026-2033, (US$ Billion)

    • Introduction

      • Market Share Analysis, By Region, 2026 and 2033 (%)

      • Y-o-Y Growth Analysis, For Regions, 2022–2033

      • Regional Trends

    • North America

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, en2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        • U.S.

        • Canada

    • Latin America

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        • Brazil

        • Mexico

        • Argentina

        • Rest of Latin America

    • Europe

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        • U.K.

        • Germany

        • Italy

        • France

        • Spain

        • Russia

        • Benelux

        • Denmark

        • Norway

        • Sweden

        • Rest of Europe

    • Asia Pacific

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026-2033, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        • China

        • Taiwan

        • India

        • Japan

        • Indonesia

        • Malaysia

        • Philippines

        • Singapore

        • Australia

        • South Korea

        • Rest of Asia Pacific

o    Middle East & Africa

  1. Introduction

  2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026-2033, (US$ Billion)

  3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)

  4. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026-2033, (US$ Billion)

  5. Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

    1. Bahrain

    2. Kuwait

    3. Oman

    4. Qatar

    5. Saudi Arabia

    6. UAE

    7. Israel

    8. South Africa

    9. North Africa

    10. Central Africa

    11. Rest of the Middle East

  1. Competitive Landscape

    • Moderna Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • BioNTech SE

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • GlaxoSmithKline plc

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Merck & Co. Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Pfizer, Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Inovio Pharmaceuticals Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Bavarian Nordik

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Agenus Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • CureVac, N.V.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Vaxart, Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

  2. Section

    • Research Methodology

    • About Us

© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.